Jason J Bailey, MD
Interventional Radiology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 14 years
- Albert Einstein College of Medicine of Yeshiva University, 2012
Offices
5 locations · California Imaging Institute Medical Group Inc · Central Valley Community Medical Imaging · Regents of the Univ of CA · Southern California Permanente Medical Group · Permanente Medical Group Inc
Looking this up.
Hospitals listed: Clovis Community Medical Center · Community Regional Medical Center · Kaiser Foundation Hospital - San Marcos · Kaiser Foundation Hospital - Zion · University of California Davis Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bailey’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A146182 · Current
Licensed to practise in California · since 2016 · expires 2028-06-30 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
- Kaiser Foundation Hospital - San DiegoSan Diego, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 4 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.204, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.627, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.164, Oct 2024 – Sep 2025
- Kaiser Foundation Hospital - San MarcosSan Marcos, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPatients rate it 4 of 5 · 88% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- University of California Davis Medical CenterSacramento, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UC Davis Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 1.94 (1.18 to 2.71) · 3,010 cases, Jul 2022 – Jun 2024Worse than the national rate — MRSA Bacteremia: 1.564, Oct 2024 – Sep 2025Worse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 6.7 (5.6 to 8) · 1,134 cases, Jan 2024 – Dec 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.6 (10.9 to 14.5) · 1,134 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 127.46 (95.81 to 159.1) · 281 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.18 (0 to 0.57) · 12,625 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.677, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.713, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,436 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Kaiser Foundation Hospital - San Diego
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.204 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.627 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.5 (0.45 to 2.54) · 400 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.01 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 332 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 5,878 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,732 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,721 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.73 (1.33 to 6.12) · 434 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.35 (0.72 to 3.98) · 421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (0.49 to 18.28) · 181 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.41 (1.35 to 9.47) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0 to 1.51) · 1,270 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 279 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.757 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.629 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 158 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,165 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 33.1 · 30 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 960 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 300 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 285 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,483 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Kaiser Foundation Hospital - San Marcos
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 0 better, 6 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 0 worse of 1 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.05 (0 to 2.14) · 31 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.48 to 1.5) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 11.9 · 85 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,689 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.45) · 152 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 155 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0 to 1.91) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 25 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.378 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.16 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.732 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.381 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.011 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 39 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 333 cases | None | Jul 2023 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 350 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 28 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 90 cases | None | Jul 2023 – Jun 2025 |
What patients said (559 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 67% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 81% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 86% |
| Staff "always" explained new medications | 80% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 64% |
| "YES", patients would definitely recommend the hospital | 88% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
See every measure and the patient survey for University of California Davis Medical Center
Behind the star rating — Deaths: 4 better, 4 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 1 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.94 (1.18 to 2.71) · 3,010 cases | Worse | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 1.564 | Worse | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.6 to 8) · 1,134 cases | Worse | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (10.9 to 14.5) · 1,134 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 127.46 (95.81 to 159.1) · 281 cases | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.57) · 12,625 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.677 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.713 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,436 cases | Better | Jan 2024 – Dec 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.78 to 1.19) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.2 · 115 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 662 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.1 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 406 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 4,328 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.05 to 0.39) · 13,828 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.13 to 0.46) · 14,152 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.29 (2.92 to 5.66) · 4,920 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.78 (0.46 to 3.09) · 2,250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (1.06 to 3.09) · 4,696 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.46 (5.18 to 13.75) · 2,102 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.35 (3.74 to 8.96) · 2,191 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.48 (1.19 to 3.77) · 1,169 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 127 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.826 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.669 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 131 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 751 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -25.8 · 127 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 24.1 · 758 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 23.6 · 477 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 469 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 140 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.3 · 203 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (9.4 to 14.9) · 2,643 cases | No different | Jan 2022 – Dec 2024 |
What patients said (2,768 patients answered, 18% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 61% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$1,260,322
Medicare paid this office $1,260,322 for 3,333 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine study from skull base to mid-thigh with ct scan | 291 | $459,443 | $1,363 |
| Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries | 72 | $203,608 | $2,828 |
| Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 33 | $186,783 | $845 |
| Nuclear medicine study limited area with ct scan | 72 | $98,148 | $1,363 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 288 | $94,446 | $279 |
See all 79 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 291 | $459,443 | $1,363 |
| Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries | 72 | $203,608 | $2,828 |
| Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 33 | $186,783 | $845 |
| Nuclear medicine study limited area with ct scan | 72 | $98,148 | $1,363 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 288 | $94,446 | $279 |
| Nuclear medicine study whole body with ct scan | 28 | $43,432 | $1,357 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 353 | $36,945 | $85 |
| Ct scan of abdomen and pelvis with contrast | 37 | $9,438 | $255 |
| Mri scan of abdomen before and after contrast | 34 | $9,078 | $267 |
| Ct scan of abdomen and pelvis before and after contrast | 28 | $7,566 | $270 |
| Ct scan of abdomen and pelvis with contrast | 116 | $7,125 | $61 |
| Ct scan of chest without contrast | 49 | $5,351 | $109 |
| Nuclear medicine study whole body with ct scan | 45 | $5,102 | $85 |
| X-ray of chest, 1 view | 543 | $4,149 | $6 |
| Mri scan of pelvis before and after contrast | 14 | $4,065 | $290 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 351 | $3,800 | $0 |
| Ct scan of chest with contrast | 34 | $3,419 | $101 |
| Ct scan of blood vessels of chest with contrast | 52 | $3,135 | $60 |
| X-ray of chest, 2 views | 378 | $3,054 | $8 |
| Ct scan of abdomen and pelvis without contrast | 45 | $2,921 | $64 |
| Complete ultrasound scan of abdomen | 29 | $2,697 | $93 |
| Ct scan of chest without contrast | 65 | $2,435 | $37 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $2,238 | $55 |
| Ct scan head or brain without contrast | 73 | $2,140 | $29 |
| Complete ultrasound scan behind abdominal cavity | 28 | $2,132 | $76 |
| Nuclear medicine study of lung ventilation and circulation | 53 | $2,111 | $39 |
| Nuclear medicine study of liver and bile duct system | 82 | $2,108 | $25 |
| Ct scan of abdomen and pelvis without contrast | 13 | $2,027 | $156 |
| Ct scan of chest with contrast | 42 | $1,562 | $37 |
| X-ray of knee, 4 or more views | 29 | $1,409 | $39 |
| Nuclear medicine study of parathyroid with spect | 31 | $1,317 | $42 |
| Complete ultrasound scan behind abdominal cavity | 46 | $1,210 | $26 |
| Ultrasound scan of head and neck soft tissue | 13 | $1,206 | $93 |
| Nuclear medicine study of bone and/or joint whole body | 38 | $1,149 | $30 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 11 | $1,103 | $100 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 27 | $1,030 | $38 |
| X-ray of shoulder, minimum of 2 views | 29 | $993 | $28 |
| Mri scan of pelvis before and after contrast | 12 | $982 | $82 |
| Complete ultrasound scan of pelvis | 12 | $973 | $81 |
| Nuclear medicine study of stomach to assess emptying | 35 | $928 | $27 |
| Injection, gadobutrol, 0.1 ml | 48 | $862 | $0 |
| Ct scan of abdomen and pelvis before and after contrast | 11 | $822 | $75 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 32 | $789 | $25 |
| Mri scan of abdomen without contrast | 14 | $744 | $53 |
| Ct scan of upper spine without contrast | 18 | $666 | $37 |
| Nuclear medicine studies of kidney, blood flow, and function | 11 | $614 | $47 |
| X-ray of chest, 2 views | 22 | $599 | $27 |
| Limited ultrasound scan of abdomen | 29 | $579 | $20 |
| X-ray of knee, 4 or more views | 60 | $577 | $8 |
| X-ray of lower and sacral spine, 2-3 views | 64 | $548 | $8 |
| X-ray of shoulder, minimum of 2 views | 69 | $512 | $7 |
| Nuclear medicine study to assess blood loss | 14 | $503 | $36 |
| X-ray of foot, minimum of 3 views | 74 | $497 | $6 |
| X-ray of abdomen, 1 view | 61 | $491 | $7 |
| X-ray of hip, 2-3 views | 59 | $454 | $8 |
| X-ray of abdomen, 1 view | 17 | $431 | $25 |
| X-ray lower and sacral spine, minimum of 6 views | 35 | $376 | $11 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 24 | $360 | $15 |
| X-ray of lower and sacral spine, minimum of 4 views | 38 | $336 | $9 |
| X-ray of upper spine, 2-3 views | 40 | $325 | $8 |
| Complete ultrasound scan of abdomen | 12 | $297 | $25 |
| X-ray of hand, minimum of 3 views | 34 | $269 | $6 |
| 3d radiographic procedure | 12 | $249 | $21 |
| X-ray of pelvis, 1-2 views | 35 | $246 | $6 |
| X-ray of knee, 3 views | 31 | $223 | $7 |
| X-ray of ankle, minimum of 3 views | 28 | $206 | $6 |
| X-ray of thigh bone, minimum 2 views | 27 | $194 | $7 |
| X-ray of middle spine, 3 views | 23 | $188 | $8 |
| X-ray of upper spine, 4-5 views | 20 | $183 | $9 |
| X-ray of lower leg, 2 views | 27 | $165 | $6 |
| X-ray of middle spine, 2 views | 20 | $162 | $8 |
| X-ray of wrist, minimum of 3 views | 26 | $160 | $6 |
| X-ray of knee, 1-2 views | 23 | $153 | $6 |
| X-ray of both hips, 3-4 views | 13 | $135 | $10 |
| X-ray of ribs on side of body, minimum of 3 views | 12 | $122 | $9 |
| X-ray of elbow, minimum of 3 views | 16 | $93 | $6 |
| 3d radiographic procedure | 11 | $89 | $7 |
| X-ray of upper arm, minimum of 2 views | 13 | $80 | $6 |
| X-ray of forearm, 2 views | 12 | $67 | $6 |
Who their Medicare patients are
3,333 Original Medicare patients in 2024. Average age 73 · Under 65 11% · 85 and older 12% · Women 56% · Also on Medicaid 36% · Health risk score 1.97. Above the middle of the specialty; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Diabetes 46% · Coronary heart disease 42% · Chronic kidney disease 40% · Heart failure 30% · Cancer 27% · Depression 27% · Atrial fibrillation 23% · COPD 22% · Dementia 12% · Stroke 12%.
The office billed $5,092,553, Medicare allowed $1,593,921 and paid $1,260,322; for 45,843 services of 158 kinds; $4,664 of it was for drugs given in the office and $1,255,658 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 3,333 | 45,843 | 73 | 1.97 | $5,092,553 | $1,260,322 |
| 2023 | 3,487 | 44,175 | 73 | 1.94 | $3,916,287 | $878,974 |
| 2022 | 3,806 | 44,880 | 73 | 1.93 | $3,484,452 | $780,629 |
| 2021 | 3,571 | 33,210 | 73 | 2.03 | $3,041,631 | $719,410 |
| 2020 | 3,687 | 34,748 | 72 | 2.12 | $2,818,931 | $553,989 |
| 2019 | 3,735 | 33,771 | 72 | 2.15 | $2,719,697 | $483,950 |
| 2018 | 1,697 | 16,337 | 72 | 2.01 | $1,320,269 | $245,051 |
| 2017 | 11 | 11 | 65 | 3.17 | $2,979 | $91 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 72 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 242 | $387,406 | $1,350 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 269 | $89,932 | $282 |
| Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 12 | $64,690 | $840 |
| Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries | 24 | $63,222 | $2,634 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 419 | $45,246 | $86 |
| Nuclear medicine study whole body with ct scan | 27 | $43,485 | $1,359 |
| Nuclear medicine study limited area with ct scan | 24 | $32,304 | $1,346 |
| Ct scan of abdomen and pelvis with contrast | 51 | $13,117 | $257 |
| Ct scan of abdomen and pelvis before and after contrast | 30 | $8,356 | $279 |
| Mri scan of abdomen before and after contrast | 28 | $8,215 | $293 |
| Ct scan of chest without contrast | 77 | $7,898 | $100 |
| Ct scan of abdomen and pelvis with contrast | 116 | $7,345 | $63 |
| Nuclear medicine study whole body with ct scan | 50 | $6,176 | $91 |
| X-ray of chest, 1 view | 562 | $4,247 | $7 |
| Mri scan of pelvis before and after contrast | 14 | $4,206 | $300 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 337 | $4,102 | $0 |
| Complete ultrasound scan of abdomen | 44 | $3,993 | $91 |
| Ct scan of chest with contrast | 38 | $3,808 | $100 |
| Complete ultrasound scan behind abdominal cavity | 40 | $3,220 | $80 |
| Ct scan of abdomen and pelvis without contrast | 44 | $2,874 | $65 |
| X-ray of chest, 2 views | 372 | $2,862 | $7 |
| Ct scan of abdomen and pelvis without contrast | 19 | $2,550 | $134 |
| Ct scan of chest with contrast | 56 | $2,367 | $42 |
| Nuclear medicine study of liver and bile duct system | 89 | $2,330 | $26 |
| Ct scan of blood vessels of chest with contrast | 38 | $2,314 | $61 |
| Ultrasound scan of head and neck soft tissue | 26 | $2,280 | $84 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $2,158 | $54 |
| Nuclear medicine study of lung ventilation and circulation | 55 | $2,080 | $37 |
| Ct scan head or brain without contrast | 66 | $1,776 | $27 |
| Complete ultrasound scan of pelvis | 23 | $1,756 | $76 |
| Nuclear medicine study of bone and/or joint whole body | 66 | $1,747 | $26 |
| Ct scan of chest without contrast | 46 | $1,601 | $35 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 17 | $1,555 | $91 |
| Nuclear medicine study of parathyroid with spect | 32 | $1,349 | $42 |
| Nuclear medicine study of stomach to assess emptying | 43 | $1,281 | $30 |
| Nuclear medicine studies of kidney, blood flow, and function | 21 | $969 | $46 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 27 | $964 | $36 |
| Injection, gadobutrol, 0.1 ml | 42 | $825 | $0 |
| Complete ultrasound scan behind abdominal cavity | 29 | $727 | $25 |
| X-ray of lower and sacral spine, 2-3 views | 75 | $603 | $7 |
| X-ray of abdomen, 1 view | 83 | $592 | $7 |
| Nuclear medicine study to assess blood loss | 15 | $559 | $33 |
| Complete ultrasound scan of abdomen | 19 | $526 | $28 |
| X-ray of knee, 4 or more views | 55 | $504 | $8 |
| X-ray of pelvis, 1-2 views | 71 | $487 | $6 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 19 | $472 | $25 |
| X-ray of shoulder, minimum of 2 views | 59 | $418 | $6 |
| X-ray of hip, 2-3 views | 55 | $408 | $7 |
| Ct scan of upper spine without contrast | 15 | $406 | $27 |
| Ultrasound of both sides of head and neck blood flow | 13 | $393 | $30 |
| X-ray of upper spine, 2-3 views | 48 | $392 | $8 |
| Limited ultrasound scan of abdomen | 19 | $384 | $20 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 24 | $378 | $16 |
| X-ray lower and sacral spine, minimum of 6 views | 31 | $357 | $12 |
| Nuclear medicine study, whole body | 12 | $356 | $30 |
| Imaging for evaluation of swallowing function | 17 | $348 | $20 |
| X-ray of lower and sacral spine, minimum of 4 views | 45 | $333 | $7 |
| X-ray of foot, minimum of 3 views | 51 | $331 | $6 |
| X-ray of hand, minimum of 3 views | 37 | $305 | $6 |
| X-ray of chest, 2 views | 15 | $294 | $20 |
| X-ray of abdomen, 1 view | 11 | $281 | $26 |
| X-ray of thigh bone, minimum 2 views | 37 | $275 | $7 |
| X-ray of knee, 1-2 views | 44 | $273 | $6 |
| X-ray of ribs on side of body, minimum of 3 views | 22 | $228 | $10 |
| X-ray of upper spine, 4-5 views | 24 | $227 | $9 |
| X-ray of knee, 3 views | 28 | $200 | $5 |
| X-ray of middle spine, 3 views | 27 | $191 | $7 |
| X-ray of lower leg, 2 views | 30 | $186 | $6 |
| X-ray of wrist, minimum of 3 views | 26 | $175 | $6 |
| X-ray of ankle, minimum of 3 views | 27 | $169 | $6 |
| X-ray of upper arm, minimum of 2 views | 15 | $98 | $6 |
| X-ray of middle spine, 2 views | 14 | $94 | $6 |
2022: 78 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 229 | $370,204 | $1,361 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 280 | $92,123 | $283 |
| Nuclear medicine study whole body with ct scan | 36 | $53,477 | $1,371 |
| Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries | 18 | $48,532 | $2,696 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 302 | $33,255 | $88 |
| Nuclear medicine study limited area with ct scan | 18 | $24,264 | $1,348 |
| Ct scan of abdomen and pelvis with contrast | 41 | $10,767 | $256 |
| Ct scan of abdomen and pelvis before and after contrast | 33 | $10,258 | $311 |
| Mri scan of abdomen before and after contrast | 31 | $8,917 | $288 |
| X-ray of chest, 1 view | 980 | $7,858 | $7 |
| Ct scan of abdomen and pelvis with contrast | 101 | $7,139 | $71 |
| Nuclear medicine study whole body with ct scan | 48 | $5,303 | $90 |
| Ct scan of chest without contrast | 48 | $5,257 | $110 |
| Complete ultrasound scan of abdomen | 47 | $4,446 | $95 |
| Mri scan of pelvis before and after contrast | 15 | $4,303 | $287 |
| X-ray of chest, 2 views | 441 | $3,593 | $8 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 54 | $3,351 | $61 |
| Ct scan of chest with contrast | 28 | $3,336 | $115 |
| Ct scan of abdomen and pelvis without contrast | 50 | $3,301 | $66 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 330 | $3,248 | $0 |
| Ct scan of abdomen and pelvis without contrast | 20 | $3,234 | $162 |
| Nuclear medicine study of bone and/or joint whole body | 98 | $2,934 | $30 |
| Ct scan of blood vessels of chest with contrast | 41 | $2,811 | $69 |
| Nuclear medicine study of liver and bile duct system | 81 | $2,352 | $28 |
| Nuclear medicine study of lung ventilation and circulation | 51 | $2,154 | $41 |
| Complete ultrasound scan behind abdominal cavity | 22 | $2,063 | $94 |
| Ct scan of chest with contrast | 47 | $2,025 | $43 |
| Mri scan of pelvis before and after contrast | 19 | $1,650 | $87 |
| Ct scan of chest without contrast | 37 | $1,506 | $41 |
| Nuclear medicine studies of kidney, blood flow, and function | 30 | $1,469 | $49 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 13 | $1,352 | $104 |
| Complete ultrasound scan of pelvis | 14 | $1,155 | $82 |
| Nuclear medicine study of parathyroid with spect | 29 | $1,152 | $40 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 29 | $1,151 | $40 |
| Ultrasound scan of head and neck soft tissue | 11 | $1,067 | $97 |
| X-ray of knee, 4 or more views | 103 | $981 | $8 |
| Mri scan of abdomen before and after contrast | 11 | $950 | $86 |
| Nuclear medicine study of stomach to assess emptying | 32 | $932 | $29 |
| Injection, gadobutrol, 0.1 ml | 45 | $922 | $0 |
| Ct scan head or brain without contrast | 29 | $915 | $32 |
| Complete ultrasound scan behind abdominal cavity | 32 | $900 | $28 |
| Ultrasound of both sides of head and neck blood flow | 29 | $881 | $30 |
| Ct scan of abdomen and pelvis before and after contrast | 11 | $869 | $79 |
| X-ray of hip, 2-3 views | 101 | $829 | $8 |
| Complete ultrasound scan of abdomen | 24 | $768 | $32 |
| Limited ultrasound scan of abdomen | 34 | $760 | $22 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 26 | $710 | $26 |
| X-ray of abdomen, 1 view | 96 | $672 | $7 |
| Nuclear medicine study to assess blood loss | 19 | $653 | $34 |
| X-ray of foot, minimum of 3 views | 90 | $610 | $6 |
| X-ray of shoulder, minimum of 2 views | 83 | $588 | $6 |
| X-ray of pelvis, 1-2 views | 92 | $546 | $6 |
| X-ray of chest, 2 views | 39 | $445 | $11 |
| X-ray of lower leg, 2 views | 67 | $431 | $6 |
| X-ray of ankle, minimum of 3 views | 61 | $420 | $6 |
| X-ray of hand, minimum of 3 views | 52 | $410 | $7 |
| X-ray of thigh bone, minimum 2 views | 63 | $407 | $6 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 24 | $401 | $17 |
| X-ray of knee, 4 or more views | 18 | $384 | $20 |
| X-ray of lower and sacral spine, 2-3 views | 43 | $369 | $8 |
| X-ray of wrist, minimum of 3 views | 48 | $339 | $6 |
| X-ray of lower and sacral spine, minimum of 4 views | 32 | $291 | $9 |
| Imaging for evaluation of swallowing function | 15 | $276 | $18 |
| X-ray of elbow, minimum of 3 views | 36 | $259 | $7 |
| X-ray of lower and sacral spine, 2-3 views | 21 | $248 | $11 |
| X-ray of shoulder, minimum of 2 views | 18 | $239 | $13 |
| 3d radiographic procedure | 12 | $218 | $18 |
| X-ray of knee, 1-2 views | 31 | $202 | $6 |
| X-ray of upper spine, 2-3 views | 21 | $198 | $9 |
| X-ray of upper arm, minimum of 2 views | 29 | $193 | $6 |
| X-ray of upper spine, 4-5 views | 19 | $176 | $9 |
| X-ray of knee, 3 views | 21 | $167 | $6 |
| X-ray lower and sacral spine, minimum of 6 views | 13 | $145 | $11 |
| X-ray of pelvis, minimum of 3 views | 14 | $131 | $9 |
| X-ray of hand, minimum of 3 views | 11 | $108 | $9 |
| X-ray of forearm, 2 views | 17 | $103 | $6 |
| X-ray of ribs on side of body, minimum of 3 views | 11 | $96 | $9 |
| X-ray of middle spine, 3 views | 11 | $90 | $8 |
2021: 77 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 162 | $256,656 | $1,351 |
| Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries | 45 | $120,960 | $2,688 |
| Nuclear medicine study limited area with ct scan | 47 | $63,356 | $1,348 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 193 | $62,635 | $281 |
| Nuclear medicine study whole body with ct scan | 21 | $29,898 | $1,359 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 261 | $29,236 | $92 |
| Ct scan of abdomen and pelvis with contrast | 39 | $10,806 | $270 |
| Ct scan of abdomen and pelvis before and after contrast | 26 | $8,013 | $297 |
| X-ray of chest, 1 view | 921 | $7,237 | $7 |
| Mri scan of abdomen before and after contrast | 22 | $6,989 | $318 |
| Ct scan of abdomen and pelvis with contrast | 102 | $6,630 | $64 |
| Ct scan of chest without contrast | 47 | $4,995 | $106 |
| Nuclear medicine study whole body with ct scan | 40 | $4,539 | $95 |
| Nuclear medicine study of bone and/or joint whole body | 20 | $4,256 | $213 |
| Complete ultrasound scan of abdomen | 49 | $4,077 | $83 |
| Ct scan of blood vessels of chest with contrast | 61 | $3,465 | $57 |
| X-ray of chest, 2 views | 375 | $3,217 | $8 |
| Ct scan of abdomen and pelvis without contrast | 52 | $2,996 | $58 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 48 | $2,812 | $59 |
| Ct scan of chest with contrast | 24 | $2,752 | $110 |
| Ct scan of abdomen and pelvis without contrast | 16 | $2,600 | $162 |
| Nuclear medicine study of lung ventilation and circulation | 61 | $2,594 | $42 |
| Ct scan head or brain without contrast | 85 | $2,557 | $30 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 244 | $2,450 | $0 |
| Nuclear medicine study of bone and/or joint whole body | 76 | $2,393 | $31 |
| Nuclear medicine study of liver and bile duct system | 75 | $2,114 | $28 |
| Complete ultrasound scan behind abdominal cavity | 28 | $1,991 | $71 |
| Ct scan of chest with contrast | 51 | $1,941 | $38 |
| Ct scan of chest without contrast | 50 | $1,908 | $37 |
| Ultrasound scan of head and neck soft tissue | 21 | $1,654 | $79 |
| Nuclear medicine study of stomach to assess emptying | 43 | $1,316 | $31 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 29 | $1,219 | $42 |
| Mri scan of pelvis before and after contrast | 12 | $1,059 | $88 |
| Nuclear medicine studies of kidney, blood flow, and function | 20 | $996 | $50 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 12 | $985 | $82 |
| Nuclear medicine study of parathyroid with spect | 18 | $801 | $45 |
| X-ray of hip, 2-3 views | 98 | $796 | $8 |
| Complete ultrasound scan of abdomen | 29 | $786 | $27 |
| X-ray of knee, 4 or more views | 82 | $778 | $9 |
| Complete ultrasound scan of pelvis | 12 | $761 | $63 |
| X-ray of knee, 4 or more views | 29 | $722 | $21 |
| Complete ultrasound scan behind abdominal cavity | 30 | $677 | $23 |
| Ct scan of upper spine without contrast | 21 | $672 | $32 |
| Nuclear medicine study to assess blood loss | 17 | $666 | $39 |
| Ultrasound of both sides of head and neck blood flow | 20 | $633 | $32 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 27 | $630 | $23 |
| X-ray of pelvis, 1-2 views | 89 | $612 | $7 |
| X-ray of foot, minimum of 3 views | 81 | $600 | $6 |
| Injection, gadobutrol, 0.1 ml | 27 | $590 | $0 |
| X-ray of shoulder, minimum of 2 views | 65 | $508 | $7 |
| X-ray of thigh bone, minimum 2 views | 66 | $445 | $6 |
| X-ray of abdomen, 1 view | 64 | $437 | $7 |
| Limited ultrasound scan of abdomen | 19 | $427 | $22 |
| X-ray of lower and sacral spine, 2-3 views | 42 | $393 | $9 |
| X-ray of lower leg, 2 views | 55 | $392 | $6 |
| X-ray of wrist, minimum of 3 views | 45 | $356 | $7 |
| X-ray of chest, 2 views | 30 | $327 | $11 |
| X-ray of hip, 2-3 views | 19 | $319 | $16 |
| X-ray lower and sacral spine, minimum of 6 views | 11 | $316 | $29 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 23 | $273 | $12 |
| X-ray of hand, minimum of 3 views | 32 | $271 | $7 |
| Imaging for evaluation of swallowing function | 13 | $258 | $20 |
| X-ray of ankle, minimum of 3 views | 33 | $249 | $7 |
| X-ray of lower and sacral spine, minimum of 4 views | 12 | $238 | $20 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 14 | $230 | $16 |
| X-ray of shoulder, minimum of 2 views | 19 | $210 | $11 |
| X-ray of forearm, 2 views | 24 | $177 | $7 |
| X-ray of elbow, minimum of 3 views | 24 | $171 | $7 |
| X-ray of abdomen, 1 view | 11 | $157 | $14 |
| X-ray of pelvis, minimum of 3 views | 13 | $134 | $10 |
| X-ray of upper arm, minimum of 2 views | 20 | $130 | $6 |
| X-ray of upper spine, 2-3 views | 12 | $119 | $9 |
| X-ray of lower and sacral spine, minimum of 4 views | 14 | $116 | $8 |
| X-ray of knee, 1-2 views | 16 | $116 | $6 |
| X-ray of lower and sacral spine, 2-3 views | 12 | $101 | $8 |
| X-ray of knee, 3 views | 12 | $100 | $7 |
| X-ray of middle spine, 3 views | 11 | $82 | $7 |
2020: 88 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 151 | $234,995 | $1,306 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 175 | $41,080 | $198 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 231 | $26,359 | $96 |
| Nuclear medicine study whole body with ct scan | 16 | $25,266 | $1,330 |
| Nuclear medicine study of bone and/or joint whole body | 58 | $12,822 | $217 |
| Ct scan of abdomen and pelvis with contrast | 46 | $12,497 | $272 |
| Ct scan of abdomen and pelvis with contrast | 169 | $12,035 | $70 |
| Mri scan of abdomen before and after contrast | 35 | $11,153 | $319 |
| Ct scan of abdomen and pelvis before and after contrast | 32 | $10,110 | $306 |
| Ct scan of chest without contrast | 75 | $9,259 | $123 |
| Complete ultrasound scan of abdomen | 85 | $7,391 | $85 |
| X-ray of chest, 1 view | 829 | $6,636 | $7 |
| Ct scan of blood vessels of chest with contrast | 95 | $6,565 | $68 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 17 | $6,105 | $339 |
| Ct scan of abdomen and pelvis without contrast | 87 | $5,872 | $66 |
| Nuclear medicine study of parathyroid with spect | 18 | $5,542 | $308 |
| Ct scan head or brain without contrast | 167 | $4,879 | $29 |
| Nuclear medicine study whole body with ct scan | 38 | $4,605 | $100 |
| Ct scan of chest with contrast | 92 | $4,412 | $47 |
| Complete ultrasound scan behind abdominal cavity | 49 | $4,134 | $84 |
| Ct scan of abdomen and pelvis without contrast | 25 | $3,830 | $153 |
| Nuclear medicine study of liver and bile duct system | 14 | $3,662 | $262 |
| Ct scan of chest with contrast | 28 | $3,479 | $124 |
| Mri scan of pelvis before and after contrast | 11 | $3,304 | $300 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 31 | $3,247 | $105 |
| Ct scan of abdomen before and after contrast | 15 | $3,192 | $213 |
| Ultrasound scan of head and neck soft tissue | 35 | $3,119 | $89 |
| X-ray of chest, 2 views | 367 | $2,949 | $8 |
| Ct scan of chest without contrast | 65 | $2,875 | $44 |
| Complete ultrasound scan of pelvis | 37 | $2,781 | $75 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 45 | $2,581 | $57 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 246 | $2,284 | $0 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 20 | $1,937 | $97 |
| Nuclear medicine study of bone and/or joint whole body | 48 | $1,564 | $33 |
| Nuclear medicine study of liver and bile duct system | 54 | $1,469 | $27 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 18 | $1,397 | $78 |
| Nuclear medicine study of lung ventilation and circulation | 34 | $1,396 | $40 |
| Mri scan of pelvis before and after contrast | 14 | $1,277 | $91 |
| Ct scan of upper spine without contrast | 33 | $1,234 | $37 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 11 | $971 | $88 |
| Injection, gadobutrol, 0.1 ml | 47 | $923 | $0 |
| Ct scan of abdomen and pelvis before and after contrast | 11 | $917 | $83 |
| Complete ultrasound scan of abdomen | 27 | $906 | $34 |
| Nuclear medicine study of stomach to assess emptying | 28 | $875 | $31 |
| Ct scan of leg without contrast | 19 | $771 | $37 |
| Limited ultrasound scan of abdomen | 33 | $765 | $23 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 63 | $755 | $12 |
| Complete ultrasound scan behind abdominal cavity | 23 | $702 | $31 |
| Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 14 | $701 | $50 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 26 | $655 | $25 |
| X-ray of knee, 4 or more views | 69 | $641 | $8 |
| Ct scan of lower spine without contrast | 16 | $586 | $37 |
| X-ray of hip, 2-3 views | 64 | $576 | $9 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 33 | $549 | $17 |
| X-ray of chest, 2 views | 38 | $522 | $14 |
| Nuclear medicine studies of kidney, blood flow, and function | 11 | $510 | $46 |
| X-ray of pelvis, 1-2 views | 77 | $508 | $6 |
| X-ray of foot, minimum of 3 views | 66 | $485 | $7 |
| Nuclear medicine study to assess blood loss | 11 | $448 | $41 |
| Ct scan of middle spine without contrast | 11 | $434 | $39 |
| Ultrasound of both sides of head and neck blood flow | 15 | $427 | $28 |
| X-ray of lower leg, 2 views | 50 | $397 | $6 |
| X-ray of knee, 4 or more views | 16 | $385 | $24 |
| X-ray of shoulder, minimum of 2 views | 50 | $381 | $7 |
| X-ray of hip, 2-3 views | 15 | $374 | $20 |
| X-ray of lower and sacral spine, minimum of 4 views | 13 | $354 | $27 |
| 3d radiographic procedure | 18 | $348 | $19 |
| X-ray of shoulder, minimum of 2 views | 20 | $344 | $16 |
| X-ray of thigh bone, minimum 2 views | 43 | $321 | $7 |
| X-ray of lower and sacral spine, 2-3 views | 34 | $310 | $9 |
| X-ray of ankle, minimum of 3 views | 35 | $301 | $7 |
| X-ray of knee, 3 views | 12 | $289 | $22 |
| Imaging for evaluation of swallowing function | 15 | $284 | $19 |
| X-ray of abdomen, 1 view | 39 | $274 | $7 |
| Nuclear medicine study of lung ventilation | 13 | $260 | $20 |
| X-ray of hand, minimum of 3 views | 36 | $227 | $6 |
| X-ray of hand, minimum of 3 views | 15 | $214 | $12 |
| X-ray of wrist, minimum of 3 views | 31 | $204 | $6 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $163 | $15 |
| X-ray of elbow, minimum of 3 views | 22 | $161 | $7 |
| X-ray lower and sacral spine, minimum of 6 views | 12 | $153 | $13 |
| X-ray of lower and sacral spine, minimum of 4 views | 14 | $142 | $10 |
| X-ray of middle spine, 3 views | 16 | $136 | $9 |
| X-ray of knee, 3 views | 19 | $127 | $6 |
| X-ray of pelvis, minimum of 3 views | 13 | $116 | $9 |
| X-ray of abdomen, 2 views | 12 | $107 | $9 |
| X-ray of upper arm, minimum of 2 views | 16 | $105 | $6 |
| X-ray of forearm, 2 views | 16 | $78 | $5 |
2019: 85 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 112 | $156,914 | $1,245 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 123 | $27,244 | $196 |
| Ct scan of abdomen and pelvis with contrast | 324 | $23,040 | $70 |
| Nuclear medicine study whole body with ct scan | 15 | $22,615 | $1,256 |
| Ct scan of abdomen and pelvis with contrast | 63 | $16,407 | $260 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 140 | $14,254 | $96 |
| Mri scan of abdomen before and after contrast | 42 | $13,699 | $326 |
| Ct scan of abdomen and pelvis without contrast | 206 | $13,618 | $65 |
| Nuclear medicine study of bone and/or joint whole body | 46 | $11,634 | $253 |
| Ct scan head or brain without contrast | 344 | $11,114 | $31 |
| Ct scan of chest without contrast | 83 | $10,563 | $127 |
| Ct scan of abdomen and pelvis before and after contrast | 36 | $10,345 | $287 |
| Complete ultrasound scan of abdomen | 103 | $9,230 | $89 |
| Ct scan of blood vessels of chest with contrast | 128 | $8,683 | $68 |
| Ct scan of chest with contrast | 132 | $6,281 | $48 |
| Ct scan of chest with contrast | 48 | $6,047 | $123 |
| Ct scan of chest without contrast | 136 | $5,821 | $42 |
| Mri scan of pelvis before and after contrast | 15 | $5,201 | $325 |
| Nuclear medicine study of parathyroid with spect | 16 | $4,934 | $308 |
| X-ray of chest, 1 view | 585 | $4,881 | $7 |
| Complete ultrasound scan behind abdominal cavity | 58 | $4,677 | $81 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 69 | $4,109 | $59 |
| X-ray of chest, 2 views | 475 | $3,722 | $8 |
| Complete ultrasound scan of pelvis | 38 | $2,870 | $76 |
| Ct scan of upper spine without contrast | 72 | $2,792 | $38 |
| Ultrasound scan of head and neck soft tissue | 33 | $2,712 | $82 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 24 | $2,357 | $98 |
| Ct scan of abdomen and pelvis without contrast | 18 | $2,235 | $124 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 252 | $2,205 | $0 |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 16 | $1,977 | $124 |
| Nuclear medicine study of lung ventilation and circulation | 46 | $1,936 | $42 |
| Ultrasound of both sides of head and neck blood flow | 13 | $1,926 | $148 |
| Complete ultrasound scan of abdomen | 65 | $1,915 | $29 |
| Complete ultrasound scan behind abdominal cavity | 69 | $1,886 | $27 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 16 | $1,706 | $100 |
| Nuclear medicine study whole body with ct scan | 17 | $1,670 | $98 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 19 | $1,587 | $84 |
| Nuclear medicine study from skull base to mid-thigh | 21 | $1,542 | $73 |
| Ct scan of lower spine without contrast | 43 | $1,540 | $36 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 16 | $1,527 | $95 |
| Ct scan of leg without contrast | 31 | $1,220 | $37 |
| Ct scan of abdomen and pelvis before and after contrast | 14 | $1,146 | $82 |
| Ct scan of chest before and after contrast | 11 | $1,141 | $104 |
| Nuclear medicine study of bone and/or joint whole body | 33 | $1,122 | $33 |
| Limited ultrasound scan of abdomen | 51 | $1,109 | $22 |
| Mri scan of abdomen before and after contrast | 15 | $1,077 | $72 |
| Injection, gadobutrol, 0.1 ml | 54 | $1,075 | $0 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 35 | $924 | $26 |
| Nuclear medicine study of stomach to assess emptying | 28 | $885 | $31 |
| Nuclear medicine study of liver and bile duct system | 30 | $866 | $28 |
| Ct scan of middle spine without contrast | 19 | $748 | $39 |
| X-ray of shoulder, minimum of 2 views | 33 | $732 | $22 |
| Ultrasound of both sides of head and neck blood flow | 23 | $680 | $30 |
| X-ray of knee, 4 or more views | 23 | $621 | $25 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 53 | $616 | $12 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 18 | $583 | $32 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 32 | $563 | $18 |
| Ct scan of leg with contrast material | 12 | $516 | $43 |
| Ct scan of face without contrast | 17 | $504 | $30 |
| Imaging for evaluation of swallowing function | 22 | $480 | $22 |
| X-ray of chest, 2 views | 29 | $476 | $16 |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 15 | $465 | $31 |
| X-ray of hip, 2-3 views | 57 | $454 | $8 |
| Ct scan of pelvis without contrast | 12 | $451 | $38 |
| 3d radiographic procedure | 23 | $440 | $19 |
| Nuclear medicine study of radioactive material distribution at sites of inflammation in whole body | 11 | $376 | $34 |
| Complete ultrasound scan of pelvis | 14 | $332 | $24 |
| Ultrasound scan of chest | 15 | $328 | $22 |
| X-ray of knee, 4 or more views | 38 | $323 | $8 |
| X-ray of foot, minimum of 3 views | 47 | $318 | $6 |
| X-ray of pelvis, 1-2 views | 46 | $309 | $7 |
| X-ray of shoulder, minimum of 2 views | 40 | $285 | $7 |
| X-ray of abdomen, 1 view | 15 | $285 | $19 |
| X-ray of abdomen, 1 view | 33 | $232 | $7 |
| X-ray of foot, minimum of 3 views | 11 | $231 | $21 |
| X-ray of hand, minimum of 3 views | 32 | $208 | $6 |
| X-ray of elbow, minimum of 3 views | 26 | $175 | $6 |
| X-ray of lower and sacral spine, 2-3 views | 21 | $166 | $8 |
| X-ray of thigh bone, minimum 2 views | 22 | $164 | $7 |
| X-ray of lower leg, 2 views | 23 | $145 | $6 |
| X-ray of ankle, minimum of 3 views | 19 | $144 | $7 |
| X-ray of upper arm, minimum of 2 views | 17 | $124 | $7 |
| X-ray of wrist, minimum of 3 views | 18 | $115 | $5 |
| X-ray of forearm, 2 views | 17 | $110 | $6 |
| X-ray of knee, 1-2 views | 15 | $90 | $6 |
2018: 51 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 66 | $81,559 | $1,236 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 85 | $16,526 | $194 |
| Nuclear medicine study from skull base to mid-thigh | 11 | $13,592 | $1,236 |
| Ct scan of abdomen and pelvis with contrast | 152 | $11,660 | $73 |
| Ct scan of abdomen and pelvis with contrast | 37 | $9,854 | $259 |
| Nuclear medicine study of bone and/or joint whole body | 27 | $7,217 | $267 |
| Ct scan of abdomen and pelvis without contrast | 85 | $6,038 | $70 |
| Ct scan of chest without contrast | 43 | $5,714 | $133 |
| Ct scan head or brain without contrast | 148 | $5,092 | $33 |
| Ct scan of abdomen and pelvis before and after contrast | 17 | $4,404 | $259 |
| Mri scan of abdomen before and after contrast | 12 | $4,335 | $361 |
| Ct scan of chest with contrast | 28 | $3,841 | $132 |
| Ct scan of blood vessels of chest with contrast | 54 | $3,835 | $71 |
| Complete ultrasound scan of abdomen | 38 | $3,768 | $99 |
| Ct scan of chest without contrast | 62 | $2,898 | $46 |
| Ct scan of chest with contrast | 56 | $2,705 | $48 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 24 | $2,425 | $97 |
| X-ray of chest, 2 views | 250 | $2,190 | $9 |
| X-ray of chest, 1 view | 243 | $2,000 | $7 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 26 | $1,683 | $65 |
| Complete ultrasound scan behind abdominal cavity | 19 | $1,605 | $84 |
| Complete ultrasound scan of pelvis | 16 | $1,426 | $89 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 12 | $1,245 | $104 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 138 | $1,208 | $0 |
| Ct scan of lower spine without contrast | 25 | $1,040 | $40 |
| Ct scan of upper spine without contrast | 23 | $993 | $43 |
| Nuclear medicine study of lung ventilation and circulation | 20 | $859 | $43 |
| Complete ultrasound scan behind abdominal cavity | 24 | $710 | $30 |
| Complete ultrasound scan of abdomen | 20 | $658 | $33 |
| Limited ultrasound scan of abdomen | 25 | $543 | $22 |
| X-ray of knee, 4 or more views | 14 | $500 | $31 |
| Ultrasound of both sides of head and neck blood flow | 15 | $485 | $32 |
| Nuclear medicine study of bone and/or joint whole body | 14 | $468 | $33 |
| Nuclear medicine study of liver and bile duct system | 15 | $447 | $30 |
| Ct scan of leg without contrast | 11 | $446 | $41 |
| Injection, gadobutrol, 0.1 ml | 16 | $372 | $0 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 28 | $337 | $12 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 11 | $326 | $27 |
| X-ray of chest, 2 views | 19 | $318 | $17 |
| Imaging for evaluation of swallowing function | 13 | $283 | $22 |
| X-ray of hip, 2-3 views | 27 | $249 | $9 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 13 | $236 | $18 |
| X-ray of abdomen, 1 view | 21 | $165 | $8 |
| X-ray of lower and sacral spine, 2-3 views | 14 | $129 | $9 |
| X-ray of foot, minimum of 3 views | 16 | $124 | $7 |
| X-ray of shoulder, minimum of 2 views | 16 | $116 | $7 |
| X-ray of wrist, minimum of 3 views | 18 | $115 | $6 |
| X-ray of hand, minimum of 3 views | 12 | $101 | $7 |
| X-ray of thigh bone, minimum 2 views | 13 | $101 | $8 |
| X-ray of pelvis, 1-2 views | 11 | $86 | $7 |
| X-ray of lower leg, 2 views | 11 | $69 | $6 |
Medicaid work
$17,688 in 2024
Medicaid paid $17,688 for 2,186 billed services this clinician did in 2024, up to 90 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 225 | $10,173 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 233 | $3,104 |
| Radiologic examination, chest; single view | 760 | $1,251 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 16 | $1,026 |
| Radiologic examination, chest; 2 views | 415 | $772 |
| Computed tomography, head or brain; without contrast material | 61 | $476 |
| HEPATOBILIARY SYST IMAGING INCLUDING GALLBLADDER | 79 | $424 |
| X-RAY EXAM OF FOOT | 145 | $125 |
| X-RAY EXAM OF SHOULDER | 48 | $106 |
| X-ray of abdomen, 1 view | 40 | $73 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 54 | $55 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 27 | $52 |
| 2024 | 2,186 | 15 | 90 | $17,688 |
| 2023 | 3,332 | 26 | 185 | $19,636 |
| 2022 | 6,050 | 27 | 264 | $19,047 |
| 2021 | 3,807 | 24 | 211 | $12,087 |
| 2020 | 3,214 | 20 | 157 | $15,832 |
| 2019 | 2,391 | 14 | 85 | $17,137 |
| 2018 | 1,919 | 23 | 141 | $17,153 |
See the largest Medicaid services in earlier years
2023
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 404 | $11,623 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 222 | $2,794 |
| Radiologic examination, chest; single view | 1,129 | $1,748 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 91 | $967 |
| Radiologic examination, chest; 2 views | 492 | $656 |
| Computed tomography, head or brain; without contrast material | 46 | $478 |
| HEPATOBILIARY SYST IMAGING INCLUDING GALLBLADDER | 85 | $323 |
| X-RAY EXAM OF SHOULDER | 90 | $128 |
| X-RAY EXAM OF FOOT | 231 | $81 |
| Ultrasound by transvaginal approach | 17 | $74 |
| Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 20 | $74 |
| Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing | 12 | $71 |
2022
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 287 | $7,591 |
| Radiologic examination, chest; single view | 1,846 | $2,592 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 149 | $2,080 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 141 | $1,354 |
| Radiologic examination, chest; 2 views | 914 | $1,102 |
| HEPATOBILIARY SYST IMAGING INCLUDING GALLBLADDER | 81 | $606 |
| Radiologic examination, knee; complete, 4 or more views | 269 | $410 |
| X-RAY EXAM OF HAND | 306 | $404 |
| X-RAY EXAM OF FOOT | 334 | $300 |
| X-RAY EXAM OF ANKLE | 266 | $299 |
| Radiologic examination; tibia and fibula, 2 views | 239 | $277 |
| CT ABDOMEN & PELVIS W/O CONTRAST MATERIAL | 25 | $259 |
2021
| Radiologic examination, chest; single view | 1,824 | $3,607 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 116 | $2,560 |
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 56 | $1,428 |
| Radiologic examination, chest; 2 views | 570 | $1,190 |
| X-RAY EXAM OF HAND | 176 | $388 |
| HEPATOBILIARY SYST IMAGING INCLUDING GALLBLADDER | 37 | $339 |
| Radiologic examination, knee; complete, 4 or more views | 155 | $323 |
| X-RAY EXAM OF ANKLE | 129 | $304 |
| Radiologic examination; tibia and fibula, 2 views | 136 | $258 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 29 | $238 |
| Computed tomography, head or brain; without contrast material | 33 | $233 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 17 | $225 |
2020
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 198 | $5,660 |
| Radiologic examination, chest; single view | 1,382 | $3,612 |
| Radiologic examination, chest; 2 views | 678 | $1,344 |
| Computed tomography, head or brain; without contrast material | 100 | $1,037 |
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 32 | $1,030 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 33 | $663 |
| X-RAY EXAM OF HAND | 125 | $333 |
| CT ABDOMEN & PELVIS W/O CONTRAST MATERIAL | 18 | $319 |
| Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing | 15 | $289 |
| X-RAY EXAM OF ANKLE | 114 | $261 |
| X-RAY EXAM OF SHOULDER | 92 | $246 |
| Radiologic examination; tibia and fibula, 2 views | 82 | $208 |
2019
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 342 | $7,733 |
| Radiologic examination, chest; single view | 774 | $3,154 |
| Computed tomography, head or brain; without contrast material | 292 | $1,753 |
| Radiologic examination, chest; 2 views | 679 | $1,293 |
| CT ABDOMEN & PELVIS W/O CONTRAST MATERIAL | 73 | $1,160 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 51 | $945 |
| Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing | 36 | $366 |
| Ultrasound, abdominal, real time with image documentation; complete | 20 | $225 |
| ECHO EXAM OF ABDOMEN | 41 | $204 |
| X-ray of abdomen, 1 view | 18 | $130 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 12 | $94 |
| X-RAY EXAM OF HAND | 29 | $38 |
2018
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 274 | $7,591 |
| Computed tomography, head or brain; without contrast material | 153 | $1,606 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 72 | $1,566 |
| Radiologic examination, chest; single view | 341 | $1,251 |
| CT ABDOMEN & PELVIS W/O CONTRAST MATERIAL | 69 | $1,134 |
| Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing | 48 | $920 |
| Radiologic examination, chest; 2 views | 498 | $740 |
| Ultrasound, abdominal, real time with image documentation; complete | 96 | $708 |
| ECHO EXAM OF ABDOMEN | 83 | $447 |
| US RETROPERITONEAL REAL TIME W/IMAGE COMPLETE | 28 | $297 |
| Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 62 | $275 |
| EXTREMITY STUDY | 13 | $257 |
Drugs they prescribed that Part D paid
$183
Pharmacies billed $183 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 33) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
33 generic and 0 brand-name prescriptions · $183 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prednisone | 24 | $60 | $2 |
Money from drug and device companies
$77 in 2025
| 2025 | 3 | 5 | None | $77 |
| 2024 | 2 | 2 | None | $76 |
| 2023 | 1 | 1 | None | $17 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| DePuy Synthes Sales | Matrixmandible | $42 | 2 payments
|
| Edwards Lifesciences | Pascal | $20 | 1 payment
|
| Electromed | Smartvest | $15 | 2 payments
|
See all 5 published payments
| Electromed | Meals · 2025-06-18 | Smartvest | $14 |
| Electromed | Meals · 2025-06-17 | Smartvest | $1 |
| Edwards Lifesciences | Meals · 2025-06-03 | Pascal | $20 |
| DePuy Synthes Sales | Meals · 2025-04-02 | Matrixmandible | $22 |
| DePuy Synthes Sales | Meals · 2025-01-13 | Matrixmandible | $20 |
See earlier years (2024, 2023)
2024: $76
| DePuy Synthes Sales | Matrixwave | $60 | 1 payment
|
| ABC Home Medical Supply | None | $16 | 1 payment
|
2023: $17
| Canon Medical Systems USA | Pet-Ct Scanner | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1265708341
- Licence
- CA A146182California A146182: Current · expires 2028-06-30
- Trained
- Albert Einstein College of Medicine of Yeshiva University, 2012 · 14 years ago
- Group
- California Imaging Institute Medical Group Inc · Central Valley Community Medical Imaging · Regents of the Univ of CA · Southern California Permanente Medical Group · Permanente Medical Group Inc
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Diagnostic radiology (2085R0202X)
- Mailing address
- 1867 E Fir Ave Ste 104, Fresno, CA, 93720
- NPI first listed
- 2012-03-22
- NPI last updated
- 2025-10-20
- NPI record certified
- 2025-10-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3600 Minnesota Dr Ste 800, Edina, MN, 55435 · 1510 E Herndon Ave Ste 110, Fresno, CA, 93720 · 505 Parnassus Ave, San Francisco, CA, 94143
This office lists an electronic records connection.